Atlas Trials

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Clinical trial NCT05561387 · RECRUITING

Trial details

NCT number
NCT05561387
Sponsor
SWOG Cancer Research Network
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Plasma Cell Myeloma
Start date
2023-10-12
Primary completion
2031-05-30
Enrollment
510

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.